The California Stem Cell Report
Subscribe
Sign in
Home
sustainability
cirm future
CIRM's $3.9 Billion Priority …
A CIRM Primer -- A to Z
Leaderboard
About
cirm future
Latest
Top
Discussions
CIRM's 'Daring,' $26 Million Bet on a Treatment for a Deadly Muscular Disease
Capricor and Cedars-Sinai researchers involved
Nov 5
•
David Jensen
1
Share this post
CIRM's 'Daring,' $26 Million Bet on a Treatment for a Deadly Muscular Disease
david293.substack.com
Copy link
Facebook
Email
Note
Other
California is Building a New Path to Rare Disease Cures; First Target is Neuro Afflictions
Fresh details unveiled last week by CIRM
Oct 29
•
David Jensen
Share this post
California is Building a New Path to Rare Disease Cures; First Target is Neuro Afflictions
david293.substack.com
Copy link
Facebook
Email
Note
Other
Six Month Pause on Research Applications at California's Stem Cell and Gene Therapy Program
Multibillion-dollar enterprise needs time to work through its sweeping, new priorities
Oct 4
•
David Jensen
2
Share this post
Six Month Pause on Research Applications at California's Stem Cell and Gene Therapy Program
david293.substack.com
Copy link
Facebook
Email
Note
Other
'All Not Well in Gene Therapy World' -- Denial of Coverage, Delays and Complications
Implications for $12 billion California program and its mandate for affordability
Sep 17
•
David Jensen
1
Share this post
'All Not Well in Gene Therapy World' -- Denial of Coverage, Delays and Complications
david293.substack.com
Copy link
Facebook
Email
Note
Other
California Plan to Maximize Impact of $3.9 Billion for Stem Cell/Gene Therapies Clears Critical Hurdle
Major goals? Fifteen to 20 new, late stage clinical trials, six to 10 rare disease treatments ready for commercialization
Sep 13
•
David Jensen
Share this post
California Plan to Maximize Impact of $3.9 Billion for Stem Cell/Gene Therapies Clears Critical Hurdle
david293.substack.com
Copy link
Facebook
Email
Note
Other
Rare Diseases Receive Preliminary Research Boost From California's Gene Therapy/Stem Cell Agency
$3.9 billion worth of new priorities under review, only one more public session before full CIRM board action
Aug 19
•
David Jensen
3
Share this post
Rare Diseases Receive Preliminary Research Boost From California's Gene Therapy/Stem Cell Agency
david293.substack.com
Copy link
Facebook
Email
Note
Other
Want to Help Plan the Financial Future of a Multibillion-Dollar, Biomedical, California Research Enterprise?
The job involves 'CIRM's lifespan' along with audits and accounting.
Aug 15
•
David Jensen
1
Share this post
Want to Help Plan the Financial Future of a Multibillion-Dollar, Biomedical, California Research Enterprise?
david293.substack.com
Copy link
Facebook
Email
Note
Other
Text from UCLA Researcher Donald Kohn on his Bubble Baby Clinical Trial
Status report and treatment of five-year-old Jakob included
Jul 27
•
David Jensen
Share this post
Text from UCLA Researcher Donald Kohn on his Bubble Baby Clinical Trial
david293.substack.com
Copy link
Facebook
Email
Note
Other
Dr. Moustache and the Bubble Baby Disease: A CIRM Success Story
More than 50 patients treated successfully, but a commercialization caveat
Jul 27
•
David Jensen
Share this post
Dr. Moustache and the Bubble Baby Disease: A CIRM Success Story
david293.substack.com
Copy link
Facebook
Email
Note
Other
Trail Guide to $3.9 Billion in Looming Changes at California's Stem Cell and Gene Therapy Program
Who wins, who loses? The priority review is laying the groundwork for decisions about dollars.
Jul 25
•
David Jensen
1
Share this post
Trail Guide to $3.9 Billion in Looming Changes at California's Stem Cell and Gene Therapy Program
david293.substack.com
Copy link
Facebook
Email
Note
Other
Looking for Work? Want to Help Give Away Billions of Dollars?
The California stem cell agency is looking for six good helpers
Jul 12
•
David Jensen
Share this post
Looking for Work? Want to Help Give Away Billions of Dollars?
david293.substack.com
Copy link
Facebook
Email
Note
Other
California's Stem Cell and Gene Therapy Priorities: New Proposal to Back 'Platform' Technologies
Latest developments in sweeping review of how the stem cell agency will spend its last billions
Jul 8
•
David Jensen
2
Share this post
California's Stem Cell and Gene Therapy Priorities: New Proposal to Back 'Platform' Technologies
david293.substack.com
Copy link
Facebook
Email
Note
Other
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts